AI Insight
The FDA has initiated a review of mifepristone, a medication used for abortion. Health experts are expressing concern that this review may not adequately consider the existing body of established scientific evidence regarding the drug's safety and efficacy. The review comes amid ongoing political debates surrounding abortion access in the United States.
Why it matters
Mifepristone has been approved for use in the U.S. for over two decades with an established safety record. Any regulatory changes to its availability could significantly impact abortion access and reproductive healthcare for millions of people, particularly in states with already restricted abortion services.
The FDA’s ongoing review of mifepristone could skip over established science, health experts warn
Source: Report: FDA just launched a study on the abortion pill